Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06673407 · ClinicalTrials.gov registry record · NA
Group Exposure Workshops for Socially Anxious Undergraduates
A NA study of Social Anxiety Disorder and Public Speaking Fear, sponsored by University of Colorado, Boulder.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT06673407: Recruiting NA study of Social Anxiety Disorder and Public Speaking Fear, sponsored by University of Colorado, Boulder.
NCT06673407 is a NA study of Social Anxiety Disorder and Public Speaking Fear that is actively recruiting participants, run by University of Colorado, Boulder. The registered enrollment target is 200 participants, above the 154-participant average among 32 other Social Anxiety Disorder trials with a reported enrollment target (30% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06673407, a NA study of Social Anxiety Disorder and Public Speaking Fear, is actively recruiting participants, sponsored by University of Colorado, Boulder.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to investigate the effects of four versions of a workshop for social anxiety and public speaking stress. All participants are current University of Colorado Boulder undergraduate students. Participation in this research study lasts for approximately 8 weeks, and includes a pre-workshop questionnaire, 3 weekly workshop sessions (ranging from 2 to 3 hours each, including a 5-minute post-session questionnaire), a post-workshop questionnaire, and a 1-month follow-up questionnaire.
Primary Outcome
Average number of workshop sessions attended by enrolled research participants.
Conditions Studied
Interventions
- BEHAVIORAL Group Exposure for Social Anxiety
- BEHAVIORAL Self-Compassion Enhanced Group Exposure Therapy for Social Anxiety
- BEHAVIORAL Peer-Enhanced Group Exposure Therapy for Social Anxiety
- BEHAVIORAL Peer and Self-Compassion Enhanced Group Exposure Therapy for Social Anxiety
Study Locations (1)
Colorado
- Renee Crown Wellness Institute and Department of Psychology & Neuroscience, University of Colorado Boulder - Boulder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-06-12 |
| Est. Completion | 2025-10-01 |
| Phase | NA |
What NCT06673407 shows while recruiting
NCT06673407 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 154-participant average among 32 other Social Anxiety Disorder trials with a reported enrollment target (30% higher).
The record links to 4 conditions, with Social Anxiety Disorder appearing as the primary indexed condition, and to 4 interventions - of which Group Exposure for Social Anxiety is the first listed.
NCT06673407 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06673407 about?
NCT06673407 is a clinical study titled "Group Exposure Workshops for Socially Anxious Undergraduates". The purpose of the study is to investigate the effects of four versions of a workshop for social anxiety and public speaking stress. All participants are current University of Colorado Boulder undergraduate students. Participation in this research study lasts for approximately 8 weeks, and includes ...
What is the current status of trial NCT06673407?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-06-12. Estimated completion is 2025-10-01.
What conditions does trial NCT06673407 study?
This clinical trial studies the following conditions: Social Anxiety Disorder, Public Speaking Fear, Public Speaking Anxiety, Social Fear.
What interventions are being tested in trial NCT06673407?
The interventions under investigation include: Group Exposure for Social Anxiety (BEHAVIORAL), Self-Compassion Enhanced Group Exposure Therapy for Social Anxiety (BEHAVIORAL), Peer-Enhanced Group Exposure Therapy for Social Anxiety (BEHAVIORAL), Peer and Self-Compassion Enhanced Group Exposure Therapy for Social Anxiety (BEHAVIORAL).
Who is sponsoring clinical trial NCT06673407?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06673407 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Social Anxiety Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06673407's enrollment target sits among peer trials
200 10th of 32 higher than 23 of 32 other Social Anxiety Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Social Anxiety Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
RECRUITING · NA
-
Individual Factors of CBT Underlying Success
RECRUITING · NA
-
Neurofeedback Enhanced Cognitive Reappraisal Training - Phase 4
RECRUITING · NA
-
Very Brief Exposure: Development of a Novel Exposure Modality for Social Anxiety Disorder in Transition-Age Youth
RECRUITING · NA
-
Targeting Social Function in Anxiety and Eating Disorders
RECRUITING · NA
-
Attention Bias Modification Training for Social Phobia (ABMSP)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI